Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Oct;57(10):880–884. doi: 10.1136/thorax.57.10.880

Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma

S Suissa 1, P Ernst 1, A Kezouh 1
PMCID: PMC1746208  PMID: 12324675

Abstract

Background: Inhaled corticosteroids are effective at preventing asthma morbidity and mortality. Most studies, however, have focused on short term effects, raising uncertainty about their effectiveness in the long term.

Methods: The Saskatchewan Health databases were used to form two population based cohorts of asthma patients aged 5–44 between 1975 and 1991. The first cohort included all subjects from the start of asthma treatment, while the second included subjects hospitalised for asthma from the date of discharge. Subjects were followed up, starting 1 year after cohort entry and continuing until 1997, 54 years of age, or death. The outcome was the first asthma hospital admission and readmission, respectively, to occur during follow up. A nested case-control design was used by which all cases were matched on calendar time and several markers of asthma severity to all available controls within the cohort.

Results: The full cohort included 30 569 asthmatic subjects of which 3894 were admitted to hospital for asthma and 1886 were readmitted. The overall rate of asthma hospitalisation was 42.4 per 1000 asthma patients per year. Regular use of inhaled corticosteroids was associated with reductions of 31% in the rate of hospital admissions for asthma (95% confidence interval (CI) 17 to 43) and 39% in the rate of readmission (95% CI 25 to 50). The rate reduction found during the first 4 years of follow up was sustained over the longer term. Regular use of inhaled corticosteroids can potentially prevent between five hospital admissions and 27 readmissions per 1000 asthma patients per year.

Conclusion: Regular use of low dose inhaled corticosteroids prevents a large proportion of hospital admissions with asthma, both early and later on in the course of the disease.

Full Text

The Full Text of this article is available as a PDF (97.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agertoft L., Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000 Oct 12;343(15):1064–1069. doi: 10.1056/NEJM200010123431502. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol. 1998 Apr;101(4 Pt 2):S427–S433. doi: 10.1016/s0091-6749(98)70154-x. [DOI] [PubMed] [Google Scholar]
  3. Blais L., Ernst P., Boivin J. F., Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 1998 Jul;158(1):126–132. doi: 10.1164/ajrccm.158.1.9707107. [DOI] [PubMed] [Google Scholar]
  4. Blais L., Suissa S., Boivin J. F., Ernst P. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax. 1998 Dec;53(12):1025–1029. doi: 10.1136/thx.53.12.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boulet L. P., Becker A., Bérubé D., Beveridge R., Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ. 1999 Nov 30;161(11 Suppl):S1–61. [PMC free article] [PubMed] [Google Scholar]
  6. Cochrane G. M. Compliance and outcomes in patients with asthma. Drugs. 1996;52 (Suppl 6):12–19. doi: 10.2165/00003495-199600526-00004. [DOI] [PubMed] [Google Scholar]
  7. Cochrane G. M., Horne R., Chanez P. Compliance in asthma. Respir Med. 1999 Nov;93(11):763–769. doi: 10.1016/s0954-6111(99)90260-3. [DOI] [PubMed] [Google Scholar]
  8. Crane J., Pearce N., Burgess C., Woodman K., Robson B., Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992 Aug;21(4):737–744. doi: 10.1093/ije/21.4.737. [DOI] [PubMed] [Google Scholar]
  9. Donahue J. G., Weiss S. T., Livingston J. M., Goetsch M. A., Greineder D. K., Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997 Mar 19;277(11):887–891. [PubMed] [Google Scholar]
  10. Freund D. A., Stein J., Hurley R., Engel W., Woomert A., Lee B. Specialty differences in the treatment of asthma. J Allergy Clin Immunol. 1989 Sep;84(3):401–406. doi: 10.1016/0091-6749(89)90428-4. [DOI] [PubMed] [Google Scholar]
  11. Gergen P. J., Weiss K. B. Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA. 1990 Oct 3;264(13):1688–1692. [PubMed] [Google Scholar]
  12. Gerstman B. B., Bosco L. A., Tomita D. K. Trends in the prevalence of asthma hospitalization in the 5- to 14-year-old Michigan Medicaid population, 1980 to 1986. J Allergy Clin Immunol. 1993 Apr;91(4):838–843. doi: 10.1016/0091-6749(93)90340-l. [DOI] [PubMed] [Google Scholar]
  13. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1991 Feb;46(2):105–111. doi: 10.1136/thx.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  15. Horwood L. J., Dawson K. P., Mogridge N. Admission patterns for childhood acute asthma: Christchurch 1974-89. N Z Med J. 1991 Jul 10;104(915):277–279. [PubMed] [Google Scholar]
  16. Hyndman S. J., Williams D. R., Merrill S. L., Lipscombe J. M., Palmer C. R. Rates of admission to hospital for asthma. BMJ. 1994 Jun 18;308(6944):1596–1600. doi: 10.1136/bmj.308.6944.1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jama J. W., Launer L. J., Witteman J. C., den Breeijen J. H., Breteler M. M., Grobbee D. E., Hofman A. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol. 1996 Aug 1;144(3):275–280. doi: 10.1093/oxfordjournals.aje.a008922. [DOI] [PubMed] [Google Scholar]
  18. Krahn M. D., Berka C., Langlois P., Detsky A. S. Direct and indirect costs of asthma in Canada, 1990. CMAJ. 1996 Mar 15;154(6):821–831. [PMC free article] [PubMed] [Google Scholar]
  19. Lubin J. H., Gail M. H. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984 Mar;40(1):63–75. [PubMed] [Google Scholar]
  20. Mitchell E. A., Bland J. M., Thompson J. M. Risk factors for readmission to hospital for asthma in childhood. Thorax. 1994 Jan;49(1):33–36. doi: 10.1136/thx.49.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith D. H., Malone D. C., Lawson K. A., Okamoto L. J., Battista C., Saunders W. B. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):787–793. doi: 10.1164/ajrccm.156.3.9611072. [DOI] [PubMed] [Google Scholar]
  23. Strachan D. P., Anderson H. R. Trends in hospital admission rates for asthma in children. BMJ. 1992 Mar 28;304(6830):819–820. doi: 10.1136/bmj.304.6830.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000 Aug 3;343(5):332–336. doi: 10.1056/NEJM200008033430504. [DOI] [PubMed] [Google Scholar]
  25. Suissa S., Ernst P., Boivin J. F., Horwitz R. I., Habbick B., Cockroft D., Blais L., McNutt M., Buist A. S., Spitzer W. O. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):604–610. doi: 10.1164/ajrccm.149.3.8118625. [DOI] [PubMed] [Google Scholar]
  26. Suissa S., Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001 Jun;107(6):937–944. doi: 10.1067/mai.2001.115653. [DOI] [PubMed] [Google Scholar]
  27. Sunyer J., Antó J. M., Tobias A., Burney P. Generational increase of self-reported first attack of asthma in fifteen industrialized countries. European Community Respiratory Health Study (ECRHS). Eur Respir J. 1999 Oct;14(4):885–891. doi: 10.1034/j.1399-3003.1999.14d26.x. [DOI] [PubMed] [Google Scholar]
  28. Tough S. C., Green F. H., Paul J. E., Wigle D. T., Butt J. C. Sudden death from asthma in 108 children and young adults. J Asthma. 1996;33(3):179–188. doi: 10.3109/02770909609054550. [DOI] [PubMed] [Google Scholar]
  29. Weiss K. B., Gergen P. J., Hodgson T. A. An economic evaluation of asthma in the United States. N Engl J Med. 1992 Mar 26;326(13):862–866. doi: 10.1056/NEJM199203263261304. [DOI] [PubMed] [Google Scholar]
  30. Weiss K. B., Sullivan S. D., Lyttle C. S. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000 Sep;106(3):493–499. doi: 10.1067/mai.2000.109426. [DOI] [PubMed] [Google Scholar]
  31. Wilkins K., Mao Y. Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. CMAJ. 1993 Jan 15;148(2):185–190. [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES